Patents by Inventor Fleur STEVENHAGEN

Fleur STEVENHAGEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Assays for measuring cardiotoxicity
    Patent number: 10613078
    Abstract: The current disclosure relates to technology for predicting cardiotoxicity of compounds. In vitro methods using human stem-cell derived cardiomyocytes cultured in specific media are disclosed, as well as kits for use in the method. In the method, the cells are treated with a test compound in combination with a mitochondrial toxicant.
    Type: Grant
    Filed: February 18, 2016
    Date of Patent: April 7, 2020
    Assignee: NCARDIA B.V.
    Inventors: Stefan Robbert Braam, Fleur Stevenhagen
  • Assays for measuring cardiotoxicity
    Publication number: 20180038846
    Abstract: The current disclosure relates to technology for predicting cardiotoxicity of compounds. In vitro methods using human stem-cell derived cardiomyocytes cultured in specific media are disclosed, as well as kits for use in the method. In the method, the cells are treated with a test compound in combination with a mitochondrial toxicant.
    Type: Application
    Filed: February 18, 2016
    Publication date: February 8, 2018
    Inventors: Stefan Robbert BRAAM, Fleur STEVENHAGEN